Rare Diseases and Orphan Drugs

Biography

Sanjay Somasundaram co-founded a technology start-up Eichiba Inc (USA) and learning’s from there helped him closely understand the commercial model of such companies. As a physician, he has experience in the pharmaceutical industry across clinical medicine, research, marketing and access. He was lead for the rare disease access program in Pfizer for five years. He and his co-author have extensively interacted with all stakeholders in the rare disease ecosystem including governments, public health experts, regulators, doctors, caregivers and patients to develop deep insights into their unmet needs and look for potential solutions.

Research Interest

Rare Diseases Eco System